Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Tables)

v3.22.1
Shareholders' Deficit (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of redemption period
Redemption Period   Redemption Percentage
1. The period beginning on the date of the issuance of shares of Series A Preferred Stock and ending on the date which is sixty days following the Issuance Date.     100%
2. The period beginning on the date that is sixty-one days from the Issuance Date and ending ninety days following the Issuance Date.     107%
3. The period beginning on the date that is ninety-one days from the Issuance Date and ending one hundred twenty days following the Issuance Date.     112%
4. The period beginning on the date that is one hundred twenty-one days from the Issuance Date and ending one hundred fifty days following the Issuance Date.     117%
5. The period beginning on the date that is one hundred fifty-one days from the Issuance Date and ending one hundred eighty days following the Issuance Date.     120%
Schedule of nonvested activity
   

Number of

Non-vested Shares

    Weighted Average Grant Date Fair Value  
Non-vested, December 31, 2018     5,998,672     $ 0.61  
Granted     12,000,000       0.05  
Forfeited     (323,373 )     (0.59 )
Non-vested, December 31, 2019     17,675,299       0.23  
Granted     7,450,000       0.04  
Shares vested     (1,298,373 )     (0.41 )
Non-vested, December 31, 2020     23,826,926     $ 0.16  
Schedule of stock option activities
    Number of Options     Weighted Average Exercise
Price
    Weighted Average Remaining Contractual Term
(Years)
    Aggregate Intrinsic
Value
 
Balance Outstanding, December 31, 2018     11,445,698     $ 0.30                  
Exercised     (3,000,000 )     0.03                  
Balance Outstanding, December 31, 2019     8,445,698       0.40                  
Exercised     -       -                  
Balance Outstanding, December 31, 2020     8,445,698     $ 0.40       5.10     $ 48,000  
Exercisable, December 31, 2020     8,445,698     $ 0.40       5.10     $ 48,000  
Schedule of warrant activities
    Number of Warrants     Weighted Average Exercise
Price
    Weighted Average Remaining Contractual Term
(Years)
    Aggregate Intrinsic
Value
 
Balance Outstanding December 31, 2018     -     $ -       -     $ -  
Granted     2,050,000       0.10                  
Cancelled     -       -                  
Balance Outstanding December 31, 2019     2,050,000     $ 0.10       4.66     $ 4,400  
Granted     288,750       0.10                  
Cancelled     (288,750 )     (0.10 )                
Exercisable, December 31, 2020     2,050,000     $ 0.05       3.66     $ 137,000